June 13, 2013
Daiichi Sankyo launched on June 11 the osteoporosis treatment Pralia Subcutaneous Injection 60 mg Syringe (recombinant denosumab), which is administered once every six months. The NHI price for one syringe is set at 28,482 yen. Its sales are expected to...read more